bullish

Benchling

The $210M/year GitHub Of Biotech

105 Views28 Jun 2024 08:00
TL;DR: Sacra estimates that Benchling hit $210M ARR in May 2024, up 27% year-over-year, with 1,200 customers for their GitHub for scientific experiments. Their upside now hinges on being the digital infrastructure underlying the proliferation of genetic engineering across every industry from agriculture to medicine. For more, check out our full report and dataset on Benchling...
What is covered in the Full Insight:
  • Introduction to Benchling
  • Financial Performance and Growth Metrics
  • Product-Market Fit and Adoption
  • Competitive Analysis
  • Future Prospects and Expansion
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • The $210M/year GitHub Of Biotech
    28 Jun 2024
x